Trials / Completed
CompletedNCT03114696
Benefit of IQP-AO-101 for Sleep
Double-blind, Placebo-controlled, Randomised Pilot Clinical Trial to Explore Benefit and Tolerability of IQP-AO-101 in Healthy Subjects With Sleep Complaints
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 50 (actual)
- Sponsor
- InQpharm Group · Industry
- Sex
- All
- Age
- 21 Years – 65 Years
- Healthy volunteers
- Accepted
Summary
The objective of this pilot clinical trial is to evaluate the potential of IQP-AO-101 with respect to sleep-promoting effects in subjects with sleep complaints.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | IQP-AO-101 | 1 dose (sachet) to be consumed 30 - 60 mins before bedtime |
| DIETARY_SUPPLEMENT | Placebo | 1 dose to be consumed 30 - 60 mins before bedtime. (Identical to investigational product) |
Timeline
- Start date
- 2017-04-25
- Primary completion
- 2017-09-29
- Completion
- 2017-09-29
- First posted
- 2017-04-14
- Last updated
- 2018-01-03
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT03114696. Inclusion in this directory is not an endorsement.